- Supported exchanges /
- AU /
- PAB.AU
Patrys Ltd (PAB AU) stock market data APIs
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. The company dvelops Deoxymab 3E10 also called PAT-DX1 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents such as radiation and many chemotherapy drugs. In addition, it develops PAT-DX3, a full-sized antibody that has DNA-targeting properties of PAT-DX1, but different pharmaceutic properties, such as tissue distribution, pharmacokinetic profile, etc. Further, it is involved in DNA targeting, blood-brain barrier, Inhibit NETosis human therapeutic applications. Patrys Limited was incorporated in 2006 and is based in Melbourne, Australia.
Patrys Ltd Financial Data Overview
| 0.007 | |
| 0.006 | |
| - | |
| 0.007 | |
| 0.006 | |
| 0.005-0.011 | |
| 12 335 K | |
| 2 056 M | |
| 1 394 K | |
| 0.422 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Patrys Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 394 K
- EBITDA -3 492 153
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Patrys Ltd Earnings via APIs
- Latest Release 2024-08-23
- EPS/Forecast NaN
Get Patrys Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
